Related Experiment Video
Updated: Jan 29, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Serum Biomarkers as Prognostic Factors for Metastatic Sarcoma.
N Aggerholm-Pedersen1, K Maretty-Kongstad2, J Keller3
1Department of Oncology, Sarcoma Centre of Aarhus, Aarhus University Hospital, Aarhus, Denmark; Department of Experimental Clinical Oncology, Sarcoma Centre of Aarhus, Aarhus University Hospital, Aarhus, Denmark.
The Aarhus composite biomarker score (ACBS) effectively predicts mortality in metastatic sarcoma patients. This composite score, combining inflammatory biomarkers, proved superior to other scoring systems for assessing patient outcomes.
Area of Science:
- Oncology
- Biomarkers
- Prognostic Indicators
Background:
- Metastatic sarcoma presents a significant challenge with high mortality rates.
- Accurate prognostic tools are crucial for managing patients with advanced sarcoma.
- Existing prognostic models may not fully capture the complexity of sarcoma progression.
Purpose of the Study:
- To evaluate the prognostic value of the Aarhus composite biomarker score (ACBS) in metastatic sarcoma.
- To assess the added prognostic information of ACBS beyond known confounders like comorbidity.
- To compare the predictive performance of ACBS against other established biomarker scoring systems.
Main Methods:
- Retrospective analysis of 265 metastatic sarcoma patients (1993-2008).
- Collection of inflammatory biomarkers: albumin, C-reactive protein, sodium, hemoglobin, neutrophils, and lymphocytes.
- Calculation of ACBS, neutrophil-to-lymphocyte ratio (NLR), Glasgow prognostic score (GPS), and combined score (CNG).
- Cox proportional hazard models and Harrell's concordance index (C-index) used for analysis, adjusted for confounders.
Main Results:
- All six individual biomarkers were independent prognostic factors for disease-specific mortality.
- Scoring systems (NLR, GPS, CNG, ACBS) combining biomarkers were also prognostic.
- The modified ACBS demonstrated superior predictive ability compared to all other scoring systems evaluated.
Conclusions:
- Biomarker scoring systems are independent prognostic factors in metastatic sarcoma.
- The Aarhus composite biomarker score (ACBS) offers superior prognostic value for predicting outcomes in metastatic sarcoma patients.
- ACBS provides a robust tool for risk stratification and clinical decision-making in advanced sarcoma.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Transcription Factors
Factors Affecting Solubility
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
Factors Affecting Drug Distribution: Miscellaneous Factors
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Electrolytes: van't Hoff Factor
The colligative properties of a solution depend only on the number, not on the identity, of solute species dissolved. The concentration terms in the equations for various colligative properties (freezing point depression, boiling point elevation, osmotic pressure) pertain to all solute species present in the solution. Nonelectrolytes dissolve physically without dissociation or any other accompanying process. Each molecule that dissolves yields one...

